Autocrine IFN-I inhibits isocitrate dehydrogenase in the TCA cycle of LPS-stimulated macrophages

J Clin Invest. 2019 Oct 1;129(10):4239-4244. doi: 10.1172/JCI127597.

Abstract

Macrophage activation in response to LPS is coupled to profound metabolic changes, typified by accumulation of the TCA cycle intermediates citrate, itaconate, and succinate. We have identified that endogenous type I IFN controls the cellular citrate/α-ketoglutarate ratio and inhibits expression and activity of isocitrate dehydrogenase (IDH); and, via 13C-labeling studies, demonstrated that autocrine type I IFN controls carbon flow through IDH in LPS-activated macrophages. We also found that type I IFN-driven IL-10 contributes to inhibition of IDH activity and itaconate synthesis in LPS-stimulated macrophages. Our findings have identified the autocrine type I IFN pathway as being responsible for the inhibition of IDH in LPS-stimulated macrophages.

Keywords: Cellular immune response; Inflammation; Macrophages; Metabolism; Mitochondria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autocrine Communication
  • Citric Acid Cycle
  • Humans
  • Interferon Type I / metabolism*
  • Interleukin-10 / metabolism
  • Isocitrate Dehydrogenase / antagonists & inhibitors*
  • Isocitrate Dehydrogenase / genetics
  • Isocitrate Dehydrogenase / metabolism
  • Lipopolysaccharides / pharmacology
  • Macrophage Activation
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, Interferon alpha-beta / deficiency
  • Receptor, Interferon alpha-beta / genetics
  • Receptor, Interferon alpha-beta / metabolism
  • Succinates / metabolism

Substances

  • IL10 protein, mouse
  • Ifnar1 protein, mouse
  • Interferon Type I
  • Lipopolysaccharides
  • Succinates
  • Interleukin-10
  • Receptor, Interferon alpha-beta
  • Isocitrate Dehydrogenase
  • itaconic acid